Palisade Bio (PALI) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.59% |
| Dec 31, 2025 | 67,566.84% |
| Sep 30, 2025 | 89.52% |
| Jun 30, 2025 | 30.03% |
| Mar 31, 2025 | -245.48% |
| Dec 31, 2024 | 153.76% |
| Sep 30, 2024 | -4,402.60% |
| Jun 30, 2024 | 106.66% |
| Mar 31, 2024 | 59.86% |
| Dec 31, 2023 | -163.98% |
| Sep 30, 2023 | -135.08% |
| Jun 30, 2023 | 240.26% |
| Mar 31, 2023 | 157.05% |
| Dec 31, 2022 | -117.79% |
| Sep 30, 2022 | 641.17% |
| Jun 30, 2022 | 56.79% |
| Mar 31, 2022 | -6.71% |
| Dec 31, 2021 | -348.73% |
| Sep 30, 2021 | -87.64% |
| Jun 30, 2021 | 12,083.67% |
| Mar 31, 2021 | -157.89% |
| Dec 31, 2020 | 95.05% |
| Sep 30, 2020 | 89.01% |
| Jun 30, 2020 | -242.15% |
| Mar 31, 2020 | 324.91% |
| Dec 31, 2019 | -143.50% |
| Sep 30, 2019 | 391.73% |
| Jun 30, 2019 | 3.39% |
| Mar 31, 2019 | -3,481.36% |
| Dec 31, 2018 | 103.90% |
| Sep 30, 2018 | 48.55% |
| Jun 30, 2018 | -186.23% |
| Mar 31, 2018 | 227.59% |
| Dec 31, 2017 | -191.13% |
| Sep 30, 2017 | 150.97% |
| Jun 30, 2017 | -46.39% |
| Mar 31, 2017 | -136.91% |
| Dec 31, 2016 | 274.57% |
| Sep 30, 2016 | -255.49% |
| Jun 30, 2016 | 20.73% |
| Mar 31, 2016 | 134.53% |
| Dec 31, 2015 | -287.62% |
| Sep 30, 2015 | 190.68% |
| Jun 30, 2015 | -560.19% |
| Mar 31, 2015 | 87.23% |
| Dec 31, 2014 | 117.46% |
| Sep 30, 2014 | -5.68% |
| Jun 30, 2014 | -307.68% |
| Mar 31, 2014 | 237.72% |
| Dec 31, 2013 | -91.52% |
| Sep 30, 2013 | 450.28% |
| Jun 30, 2013 | -128.63% |
| Mar 31, 2013 | 314.66% |
| Dec 31, 2012 | -133.13% |
| Sep 30, 2012 | 381.57% |
| Jun 30, 2012 | -193.28% |
| Mar 31, 2012 | 251.46% |
| Dec 31, 2011 | 5.29% |
| Sep 30, 2011 | 19.06% |
| Jun 30, 2011 | -236.39% |
| Mar 31, 2011 | 69.29% |
| Dec 31, 2010 | 4.49% |